Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice

Journal of Neurotrauma

Volumn 27, Issue 1, 2010, Pages 217-228

  James, Michael L ^a   Wang, Haichen ^a   Venkatraman, Talaignair ^a   Song, Pingping ^a,b   Lascola, Christopher D ^a,b   Laskowitz, Daniel T ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Brain natriuretic peptide; Cerebral blood flow; Intracerebral hemorrhage; Nesiritide; Neuroinflammation; Neuroprotection; Traumatic brain injury

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6; MESSENGER RNA; NESIRITIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CONVALESCENCE; DISEASE MARKER; DOWN REGULATION; DRUG MEGADOSE; HISTOCHEMISTRY; INFLAMMATION; LASER DOPPLER FLOWMETRY; LATENT PERIOD; LOW DRUG DOSE; MALE; MAZE TEST; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NEUROLOGIC EXAMINATION; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; ROTAROD TEST; TRAUMATIC BRAIN INJURY; WILD TYPE;

ACUTE DISEASE; ANIMALS; BRAIN; BRAIN INJURIES; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; NERVE DEGENERATION; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; ORGANIC CHEMICALS; RECOVERY OF FUNCTION; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME;

EID: 76349118340     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.1022     Document Type: Article

References (62)

1. Brosnan, M.J., Clark, J.S., Jeffs, B., Negrin, C.D., Van Vooren, P., Arribas, S.M., Carswell, H., Aitman, T.J., Szpirer, C., Macrae, I.M., and Dominiczak, A.F. (1999). Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 33, 290-297.
2. Burger, A.J., Horton, D.P., LeJemtel, T., Ghali, J.K., Torre, G., Dennish, G., Koren, M., Dinerman, J., Silver, M., Cheng, M.L., and Elkayam, U. (2002). Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am. Heart J. 144, 1102-1108.
3. Clarkson, P.B., Wheeldon, N.M., Macleod, C., Coutie, W., and MacDonald, T.M. (1995). Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects. Clin. Sci. (Lond.) 88, 159-164.
4. Di Angelantonio, E., De Castro, S., Toni, D., Sacchetti, M.L., Biraschi, F., Prencipe, M., and Fiorelli, M. (2007). Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. J. Neurol. Sci. 260, 139-142.
5. Fainardi, E., Borrelli, M., Saletti, A., Schivalocchi, R., Azzini, C., Cavallo, M., Ceruti, S., Tamarozzi, R., and Chieregato, A. (2008). CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage. Neuroradiology 50, 729-740.
6. Foda, M.A., and Marmarou, A. (1994). A new model of diffuse brain injury in rats. Part II: Morphological characterization. J. Neurosurg. 80, 301-313.
7. Hamm, R.J., Pike, B.R., O'Dell, D.M., Lyeth, B.G., and Jenkins, L.W (1994) The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J. Neurotrauma 11, 187-196.
8. Hlatky, R., Lui, H., Cherian, L., Goodman, J.C., O'Brien, W.E., Contant, C.F., Robertson, C.S. (2003). The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice. J. Neurotrauma 20, 995-1006.
9. Holscher, C. (1999). Stress impairs performance in spatial water maze learning tasks. Behav. Brain Res. 100, 225-235.
10. Ito, T., Nishimura, Y., and Saavedra, J. (2001). Pre-treatment with candesartan protects from cerebral ischaemia. J. Renin Angiotensin Aldosterone Syst. 2, 174-179.
11. Ito, T., Yamakawa, H., Bregonzio, C., Terron, J.A., Falcon-Neri, A., and Saavedra, J.M. (2002). Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33, 2297-2303.
12. James, M.L., Sullivan, P.M., Lascola, C.D., Vitek, M.P., and Laskowitz, D.T. (2008a). Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke 40, 632-639.
13. James, M.L., Warner, D.S., and Laskowitz, D.T. (2008b). Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit. Care 9, 139-152.
14. Jensen, J.K., Mickley, H., Bak, S., Korsholm, L., and Kristensen, S.R. (2006). Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc. Dis. 22, 439-444.
15. Kasama, S., Toyama, T., Kumakura, H., Takayama, Y., Ishikawa, T., Ichikawa, S., Suzuki, T., and Kurabayashi, M. (2004). Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure. J. Nucl. Med. 45, 1108-1113.
16. Kirchhoff, C., Stegmaier, J., Bogner, V., Buhmann, S., Mussack, T., Kreimeier, U., Mutschler, W., and Biberthaler, P. (2006). Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J. Neurotrauma 23, 943-949.
17. Konig, D., Neubauer, O., Nics, L., Kern, N., Berg, A., Bisse, E., and Wagner, K.H. (2007). Biomarkers of exercise-induced myocardial stress in relation to inflammatory and oxidative stress. Exerc. Immunol. Rev. 13, 15-36.
18. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D.J., Sessa, W.C., and Walsh, K. (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6, 1004-1010.
19. Laskowitz, D.T., Kasner, S.E., Saver, J., Remmel, K.S., and Jauch, E.C. (2009). Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 40, 77-85.
20. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
21. Lu, D.C., Binder, D.K., Chien, B., Maisel, A., and Manley, G.T. (2008). Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports. Surg. Neurol. 69, 226-229.
22. Luchner, A., and Schunkert, H. (2004). Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc. Res. 63, 443-449.
23. Luo, Z., Fujio, Y., Kureishi, Y., Rudic, R.D., Daumerie, G., Fulton, D., Sessa, W.C., and Walsh, K. (2000). Acute modulation of endothelial Akt=PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J. Clin. Invest. 106, 493-499.
24. Lynch, J.R., Wang, H., Mace, B., Leinenweber, S., Warner, D.S., Bennett, E.R., Vitek, M.P., McKenna, S., and Laskowitz, D.T. (2005). A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp. Neurol. 192, 109-116.
25. Ma, K.K., Ogawa, T., and de Bold, A.J. (2004). Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J. Mol. Cell Cardiol. 36, 505-513.
26. McGirt, M.J., Blessing, R., Nimjee, S.M., Friedman, A.H., Alexander, M.J., Laskowitz, D.T., and Lynch, J.R. (2004). Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 54, 1369-1373; discussion 73-74.
27. McGrath, M.F., de Bold, M.L., and de Bold, A.J. (2005). The endocrine function of the heart. Trends Endocrinol. Metab. 16, 469-477.
28. Meirovich, Y.F., Veinot, J.P., de Bold, M.L., Haddad, H., Davies, R.A., Masters, R.G., Hendry, P.J., and de Bold, A.J. (2008). Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J. Heart Lung Transplant. 27, 31-37.
29. Minambres, E., Cemborain, A., Sanchez-Velasco, P., Gandarillas, M., Diaz-Reganon, G., Sanchez-Gonzalez, U., and Leyva-Cobian, F. (2003) Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit. Care Med. 31, 933-938.
30. Modrego, P.J., Boned, B., Berlanga, J.J., and Serrano, M. (2008). Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int. J. Med. Sci. 5, 18-23.
31. Montaner, J., Perea-Gainza, M., Delgado, P., Ribo, M., Chacon, P., Rosell, A., Quintana, M., Palacios, M.E., Molina, C.A., and Alvarez-Sabin, J. (2008). Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39, 2280-2287.
32. Morikawa, E., Moskowitz, M.A., Huang, Z., Yoshida, T., Irikura, K., and Dalkara, T. (1994). L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25, 429-435.
33. Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
34. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., Yasue, H., et al. (1991). Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87, 1402-1412.
35. Mun-Bryce, S., Roberts, L., Bartolo, A., and Okada, Y. (2006). Transhemispheric depolarizations persist in the intracerebral hemorrhage swine brain following corpus callosal transection. Brain Res. 1073-1074, 481-490.
36. Mun-Bryce, S., Roberts, L.J., Hunt, W.C., Bartolo, A., and Okada, Y. (2004). Acute changes in cortical excitability in the cortex contralateral to focal intracerebral hemorrhage in the swine. Brain Res. 1026, 218-226.
37. Nakagawa, K., Yamaguchi, T., Seida, M., Yamada, S., Imae, S., Tanaka, Y., Yamamoto, K., and Ohno, K. (2005). Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc. Dis. 19, 157-164.
38. Nguyen, A.P., Huynh, H.D., Sjovold, S.B., and Colbourne, F. (2008). Progressive brain damage and alterations in dendritic arborization after collagenase-induced intracerebral hemorrhage in rats. Curr. Neurovasc. Res. 5, 171-177.
39. Orakcioglu, B., Becker, K., Sakowitz, O.W., Herweh, C., Kohrmann, M., Huttner, H.B., Steiner, T., Unterberg, A., and Schellinger, P.D. (2008). MRI of the perihemorrhagic zone in a rat ICH model: effect of hematoma evacuation. Neurocrit. Care 8, 448-455.
40. Powner, D.J., Hergenroeder, G.W., Awili, M., Atik, M.A., and Robertson, C. (2007). Hyponatremia and comparison of NTpro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: a pilot study. Neurocrit. Care 7, 119-123.
41. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF). (2002). Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287, 1531-1540.
42. Ramilo, O., Saez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K.D., Hansen, E.J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., and McCracken, G.H., Jr. (1990). Tumor necrosis factor alpha= cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp. Med. 172, 497-507.
43. Rosenberg, G.A., Estrada, E., Wesley, M., and Kyner, W.T. (1990). Autoradiographic patterns of brain interstitial fluid flow after collagenase-induced haemorrhage in rat. Acta Neurochir. Suppl. (Wien.) 51, 280-282.
44. Rubattu, S., Sciarretta, S., Valenti, V., Stanzione, R., and Volpe, M. (2008). Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am. J. Hypertens. 21, 733-741.
45. Saavedra, J.M. (2005). Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol. Neurobiol. 25, 485-512.
46. Sakata, Y., Yamamoto, K., Masuyama, T., Mano, T., Nishikawa, N., Kuzuya, T., Miwa, T., and Hori, M. (2001). Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure. J. Hypertens. 19, 1905-1912.
47. Schmued, L.C., and Hopkins, K.J. (2000). Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
48. Sudoh, T., Kangawa, K., Minamino, N., and Matsuo, H. (1988). A new natriuretic peptide in porcine brain. Nature 332, 78-81.
49. Sviri, G.E., Soustiel, J.F., and Zaaroor, M. (2006). Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir. (Wien.) 148, 529-533; discussion 33.
50. Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M., Hashimoto, R., Katsuura, G., Mukoyama, M., Itoh, H., Saito, Y., Tanaka, I., Otani, H., and Katsuki, M. (2000). Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 97, 4239-4244.
51. Tsuchiya, D., Hong, S., Kayama, T., Panter, S.S., and Weinstein, P.R. (2003). Effect of suture size and carotid clip application upon blood flow and infarct volume after permanent and temporary middle cerebral artery occlusion in mice. Brain Res. 970, 131-139.
52. Vesely, D.L., and de Bold, A.J. (2009). Cardiac natriuretic peptides gene expression and secretion in inflammation. J. Investig. Med. 57, 29-32.
53. Wang, H., Durham, L., Dawson, H., Song, P., Warner, D.S., Sullivan, P.M., Vitek, M.P., and Laskowitz, D.T. (2007a). An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 144, 1324-1333.
54. Wang, H., Lynch, J.R., Song, P., Yang, H.J., Yates, R.B., Mace, B., Warner, D.S., Guyton, J.R., and Laskowitz, D.T. (2007b). Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp. Neurol. 206, 59-69.
55. Wei, E.P., Dietrich, W.D., Povlishock, J.T., Navari, R.M., and Kontos, H.A. (1980). Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ. Res. 46, 37-47.
56. West, M.J., Ostergaard, K., Andreassen, O.A., and Finsen, B. (1996). Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370, 11-22.
57. West, M.J., Slomianka, L., and Gundersen, H.J. (1991). Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497.
58. Woiciechowsky, C., Schoning, B., Cobanov, J., Lanksch, W.R., Volk, H.D., and Docke, W.D. (2002). Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J. Trauma 52, 339-435.
59. Yamada, M., Huang, Z., Dalkara, T., Endres, M., Laufs, U., Waeber, C., Huang, P.L., Liao, J.K., and Moskowitz, M.A. (2000). Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab. 20, 709-717.
60. Yancy, C.W., Saltzberg, M.T., Berkowitz, R.L., Bertolet, B., Vijayaraghavan, K., Burnham, K., Oren, R.M., Walker, K., Horton, D.P., and Silver, M.A. (2004). Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial). Am. J. Cardiol. 94, 595-601.
61. Yemisci, M., Ay, H., Kocaefe, C., Qui, J., Topalkara, K., Ozguc, M., Kirazli, S., Ozcebe, O., Moskowitz, M.A., and Dalkara, T. (2008). Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovasc. Dis. 26, 190-198.
62. Zhou, J., Ando, H., Macova, M., Dou, J., and Saavedra, J.M. (2005). Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J. Cereb. Blood Flow Metab. 25, 878-886.